506 related articles for article (PubMed ID: 6333890)
1. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
2. Reduced natural killer T-cells in B-cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu-11, A10, AB8.28.
Foa R; Fierro MT; Lusso P; Raspadori D; Ferrando ML; Matera L; Malavasi F; Lauria F
Br J Haematol; 1986 Jan; 62(1):151-4. PubMed ID: 3484634
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and functional characterization of HTLV positive neoplastic T cells cultured with interleukin-2--I. Retention of morphology, phenotype and selective cytotoxic properties in long term culture.
Vyth-Dreese FA; de Vries JE
Leuk Res; 1984; 8(1):1-14. PubMed ID: 6321859
[TBL] [Abstract][Full Text] [Related]
4. Impaired natural killer activity in patients with chronic lymphocytic leukemia is associated with a deficiency of azurophilic cytoplasmic granules in putative NK cells.
Kay NE; Zarling JM
Blood; 1984 Feb; 63(2):305-9. PubMed ID: 6607080
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of natural killer cell activity in patients with chronic lymphocytic leukemia.
Ziegler HW; Kay NE; Zarling JM
Int J Cancer; 1981 Mar; 27(3):321-7. PubMed ID: 6169660
[TBL] [Abstract][Full Text] [Related]
6. Natural killer and antibody-dependent cytotoxic activities in T cell chronic lymphocytic leukemia.
Gupta S; Fernandes G
J Clin Lab Immunol; 1983 Nov; 12(3):155-7. PubMed ID: 6607357
[TBL] [Abstract][Full Text] [Related]
7. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
8. Expression of NK-lineage markers on peripheral blood lymphocytes with T-helper (Leu3+/T4+) phenotype in B cell chronic lymphocytic leukemia.
Velardi A; Prchal JT; Prasthofer EF; Grossi CE
Blood; 1985 Jan; 65(1):149-55. PubMed ID: 3155487
[TBL] [Abstract][Full Text] [Related]
9. Generation of non-MHC restricted killing in cultures stimulated with B cells from chronic lymphocytic leukaemia patients: phenotypic characterization of the precursor and effector cells.
Matera L; Foa R; Malavasi F; Bellone G; Funaro A; Veglia F; Santoli D
Clin Exp Immunol; 1988 May; 72(2):303-8. PubMed ID: 3261664
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for T cell abnormalities in chronic lymphocytic leukaemia of the B cell type.
Herrmann F; Sieber G; Chen Z; Enders B; Komischke B; Rühl H
Clin Exp Immunol; 1983 Jul; 53(1):109-14. PubMed ID: 6347474
[TBL] [Abstract][Full Text] [Related]
11. Patients with a deficiency of natural killer cell activity lack the VEP13-positive lymphocyte subpopulation.
Ziegler-Heitbrock HW; Rumpold H; Kraft D; Wagenpfeil C; Munker R; Abo T; Balch CM; LeBien TW
Blood; 1985 Jan; 65(1):65-70. PubMed ID: 3965053
[TBL] [Abstract][Full Text] [Related]
12. In vitro generation of NK-like activity in human PBL co-cultured with fresh T leukaemia cells.
Matera L; Foa R; Moore M
J Clin Lab Immunol; 1984 Oct; 15(2):85-90. PubMed ID: 6335181
[TBL] [Abstract][Full Text] [Related]
13. A case of chronic lymphocytic leukemia with properties characteristic of natural killer cells.
Itoh K; Tsuchikawa K; Awataguchi T; Shiiba K; Kumagai K
Blood; 1983 May; 61(5):940-8. PubMed ID: 6187398
[TBL] [Abstract][Full Text] [Related]
14. [Regulation of the natural killer activity of lymphocytes from healthy donors and patients with chronic lympholeukemia through the interaction of T- and non-T cells].
Khonina NA; Shubinskiĭ GZ; Lozovoĭ VP
Biull Eksp Biol Med; 1987 Mar; 103(3):321-3. PubMed ID: 3493815
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine induction of NK-like cytotoxicity in T cells from B-CLL.
Alvarez de Mon M; Casas J; Laguna R; Toribio ML; de Landázuri MO; Durántez A
Blood; 1986 Jan; 67(1):228-32. PubMed ID: 3079643
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of natural killer lymphocyte abnormalities in colon cancer patients.
Balch CM; Tilden AB; Dougherty PA; Cloud GA; Abo T
Surgery; 1984 Jan; 95(1):63-70. PubMed ID: 6581546
[TBL] [Abstract][Full Text] [Related]
17. Functional and multimarker analysis of T-cell chronic lymphocytic leukaemia.
Baldini L; Di Padova F; Cortelezzi A; Neri A; Nobili L; Lavezzi AM; Maiolo AT; Polli EE
Scand J Haematol; 1985 Jan; 34(1):88-96. PubMed ID: 3155872
[TBL] [Abstract][Full Text] [Related]
18. A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes.
Pegoraro L; Fierro MT; Lusso P; Giovinazzo B; Lanino E; Giovarelli M; Matera L; Foa R
J Natl Cancer Inst; 1985 Aug; 75(2):285-90. PubMed ID: 2410652
[TBL] [Abstract][Full Text] [Related]
19. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
[TBL] [Abstract][Full Text] [Related]
20. The use of VEP13 monoclonal antibody for definition of natural killer cells: spontaneous killer cells directed against fresh human leukaemia cells carry the VEP13 antigen.
Ziegler-Heitbrock HW; Fütterer A; Rumpold H; Kraft D; Munker R; Riethmüller G
Clin Exp Immunol; 1984 Nov; 58(2):470-7. PubMed ID: 6333947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
